TrialNature communications2024

Cardiovascular and renal effects of apelin in chronic kidney disease: a randomised, double-blind, placebo-controlled, crossover study.

Fiona A Chapman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.